carvedilol has been researched along with Muscular Dystrophy in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Carvedilol therapy appears to be safe for patients with DCM secondary to muscular dystrophy and produces a modest improvement in systolic and diastolic function." | 9.13 | Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. ( Colan, SD; Darras, BT; Geva, T; Jenkins, KJ; Margossian, R; Powell, AJ; Rhodes, J, 2008) |
"Carvedilol therapy appears to be safe for patients with DCM secondary to muscular dystrophy and produces a modest improvement in systolic and diastolic function." | 5.13 | Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. ( Colan, SD; Darras, BT; Geva, T; Jenkins, KJ; Margossian, R; Powell, AJ; Rhodes, J, 2008) |
"The effect of the beta-blocker, carvedilol, and/or ACEI on ventricular function in patients with muscular dystrophy was studied." | 5.12 | Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. ( Ishigaki, K; Kajimoto, H; Nakanishi, T; Nakazawa, M; Okumura, K; Osawa, M; Saito, K; Tomimatsu, H, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kajimoto, H | 1 |
Ishigaki, K | 1 |
Okumura, K | 1 |
Tomimatsu, H | 1 |
Nakazawa, M | 1 |
Saito, K | 1 |
Osawa, M | 1 |
Nakanishi, T | 1 |
Rhodes, J | 1 |
Margossian, R | 1 |
Darras, BT | 1 |
Colan, SD | 1 |
Jenkins, KJ | 1 |
Geva, T | 1 |
Powell, AJ | 1 |
2 trials available for carvedilol and Muscular Dystrophy
Article | Year |
---|---|
Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles | 2006 |
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dos | 2008 |